NRF1 and chronic obstructive pulmonary disease: To further confirm that NRF1 promoted COPD progression through p65, L132 cells were pretreated with 5 μM Bay11-7082 for 24 h to pharmacologically inhibit the NF-κB signaling before CSE and LPS treatments.